Life Sciences Tools and Services
Company Overview of Cerca Insights Sdn Bhd
Cerca Insights Sdn Bhd, a contract research organization, provides modeling for discovery stage psychiatric compounds using its transgenic chakragati (ckr) model of psychosis. It focuses on disease relevant in-vivo efficacy models to evaluate and characterize discovery stage psychiatric compounds. The company offers ckr.Screen, a screen for antipsychotic efficacy based on chakragati mouse model. It serves pharmaceutical and biotech companies. The company was formerly known as Chakra Biotech Sdn Bhd and changed its name to Cerca Insights Sdn Bhd in June 2010. The company was founded in 2007 and is based in Penang, Malaysia.
016/018 Kompleks EUREKA
Universiti Sains Malaysia
Founded in 2007
60 4 659 1903
60 4 659 1927
Key Executives for Cerca Insights Sdn Bhd
Similar Private Companies By Industry
|Cerca Insights Sdn Bhd||Asia|
|Malaysian Biotechnology Corporation Sdn. Bhd.||Asia|
|Agilent Technologies Sales Malaysia Sdn. Bhd.||Asia|
|Electron Beam Sdn Bhd||Asia|
|Inno Biologics Sdn. Bhd.||Asia|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Cerca Insights Sdn Bhd, please visit www.cercainsights.com. Company data is provided by Capital IQ. Please use this form to report any data issues.